Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 74 | 0 | 11 | 0 | €801.50 | €831.01 | 3.682% |
| Regeneron Pharmaceuticals Inc. | 53 | 1 | 7 | 0 | €922.80 | €1,080.6 | 17.101% |
| Celldex Therapeutics | 23 | 0 | 6 | 0 | €28.00 | €62.17 | 122.033% |
| Evolus Inc | 17 | 0 | 6 | 0 | €15.20 | €20.46 | 34.620% |
| Johnson & Johnson | 41 | 1 | 6 | 0 | €145.66 | €192.63 | 32.246% |
| WAVE Life Sciences Ltd | 13 | 0 | 6 | 0 | €7.70 | €14.05 | 82.416% |
| Ultragenyx Pharmaceutical Inc. | 29 | 1 | 5 | 0 | €49.00 | €82.93 | 69.247% |
| Intra-Cellular Therapies Inc. | 36 | 0 | 5 | 0 | €65.00 | €85.14 | 30.989% |
| Pfizer Inc. | 29 | 4 | 5 | 0 | €26.01 | €40.64 | 56.258% |
| Sanofi S.A. ADR | 12 | 0 | 5 | 0 | €51.00 | €55.25 | 8.341% |
| Cytokinetics Inc. | 37 | 1 | 5 | 0 | €50.50 | €82.73 | 63.814% |
| Icon plc | 27 | 0 | 5 | 0 | €269.00 | €327.46 | 21.733% |
| Halozyme Therapeutics Inc. | 25 | 0 | 4 | 0 | €53.90 | €58.58 | 8.679% |
| Exact Sciences | 20 | 0 | 4 | 0 | €61.48 | €75.89 | 23.440% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €104.50 | €144.48 | 38.258% |
| Exelixis Inc. | 22 | 0 | 4 | 0 | €23.95 | €26.01 | 8.586% |
| Merck KGaA | 8 | 1 | 4 | 0 | €154.80 | €172.00 | 11.111% |
| Bayer AG | 16 | 5 | 4 | 4 | €29.80 | €45.00 | 51.032% |
| Alnylam Pharmace. | 44 | 0 | 3 | 0 | €243.00 | €275.25 | 13.272% |
| PTC Therapeutics Inc. | 17 | 6 | 3 | 0 | €31.00 | €41.81 | 34.878% |
| MannKind Corp. | 12 | 0 | 3 | 0 | €5.85 | €6.92 | 18.334% |
| Lexicon Pharmaceuticals Inc. | 12 | 0 | 3 | 0 | €1.45 | €9.07 | 524.483% |
| Abbott Laboratories | 22 | 0 | 3 | 0 | €102.48 | €116.48 | 13.661% |
| Amgen Inc. | 29 | 1 | 3 | 1 | €290.50 | €304.82 | 4.929% |
| Immunic Inc. | 8 | 3 | 3 | 0 | €1.45 | €6.43 | 344.268% |